Drug Study Day 2
Drug Study Day 2
Drug Study Day 2
M EDICATION MECAHNISM OF INDICATION SIDE EFFECTS CONTRAINDICATION/ ADVERSE EFFECTS NURSING CONSIDERATION/
ACTION DRUG TO DRUG INTERACTION Patient Teaching
Other: anaphylaxis,
hypersensitivity reactions,
serum sickness.
GENERICNAME: Neurologically 1. Treatment for Caution with Methycobal should Nausea and vomiting, Assess for gastrointestinal complaints such as
Mecobalamin active form of vit. pt. with not be used for >1 month in dizziness, skin rash, nausea, vomiting and constipation -Asses the patient
B12 and occurs peripheral patients if no clinically sweating, anorexia and abdomen forbloating-Ask the significant other’s if the
as a water-soluble neuropathies therapeutic outcome is headache patient is experiencing headache -Report severe GI
BRANDNAME: Methycobal vitamin in the 2. Vit. B12 def. observed upset, dizziness , unusual fatigue or weakness, fever
body. It is a & chills
Classification:Vit B 12 cofactor in
theenzyme
methionine
synthase, which
functions to
transfer methyl
groupsfor the
regeneration of
methione from
Date: 6/25/24
F - Pain at IV site